Get the Stockscreener App
0.5135
2.86%
-0.0148
Inotiv Inc stock is traded at $0.5135, with a volume of 186.51K.
It is down -2.86% in the last 24 hours and down -15.77% over the past month.
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.
See More
Previous Close:
$0.5283
Open:
$0.528
24h Volume:
186.51K
Relative Volume:
0.25
Market Cap:
$17.64M
Revenue:
$505.30M
Net Income/Loss:
$-78.96M
P/E Ratio:
-0.1907
EPS:
-2.6929
Net Cash Flow:
$-46.37M
1W Performance:
-5.35%
1M Performance:
-15.77%
6M Performance:
-76.88%
1Y Performance:
-88.44%
1-Day Range:
$0.499
$0.5326
1-Week Range:
$0.499
$0.59
52-Week Range:
$0.47
$4.796
Inotiv Inc Stock (NOTV) Company Profile
Name
Inotiv Inc
Sector
Industry
Phone
(317) 463-4527
Address
2701 KENT AVE, WEST LAFAYETTE
Compare NOTV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NOTV
Inotiv Inc
|
0.5132 | 18.16M | 505.30M | -78.96M | -46.37M | -2.6929 |
|
TMO
Thermo Fisher Scientific Inc
|
624.75 | 235.43B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
235.35 | 167.20B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
697.90 | 55.72B | 4.17B | 1.03B | 940.22M | 12.61 |
|
IQV
Iqvia Holdings Inc
|
241.86 | 40.77B | 15.90B | 1.28B | 2.21B | 7.2842 |
|
A
Agilent Technologies Inc
|
135.71 | 38.46B | 6.95B | 1.30B | 1.15B | 4.5696 |
Inotiv Inc Stock (NOTV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-14-24 | Downgrade | Jefferies | Buy → Hold |
| Feb-09-24 | Upgrade | Jefferies | Hold → Buy |
| Jul-20-23 | Initiated | Wells Fargo | Overweight |
| Jan-19-23 | Downgrade | Jefferies | Buy → Hold |
| Jan-11-23 | Upgrade | Lake Street | Hold → Buy |
| Nov-18-22 | Downgrade | Lake Street | Buy → Hold |
| Oct-04-22 | Initiated | Jefferies | Buy |
| Jan-31-22 | Initiated | Lake Street | Buy |
| Sep-20-21 | Initiated | Craig Hallum | Buy |
View All
Inotiv Inc Stock (NOTV) Latest News
Aug Swings: Is MNTS stock a good pick for beginnersJuly 2025 Drop Watch & AI Powered Buy and Sell Recommendations - baoquankhu1.vn
New Highs: Is Inotiv Inc backed by strong institutional buyingJuly 2025 Fed Impact & Safe Entry Zone Tips - baoquankhu1.vn
Inotiv receives preliminary court approval for $2.49 million derivative settlement - Investing.com
Inotiv gains preliminary approval for derivative settlement agreement - TipRanks
Jobs Data: Will Host Hotels Resorts Inc benefit from sector rotationWeekly Trend Recap & Verified Technical Trade Signals - baoquankhu1.vn
Inotiv to leverage LifeNet Health’s TruVivo in translational drug discovery - TipRanks
Performance Recap: Will Inotiv Inc stock maintain growth storyPortfolio Value Summary & AI Driven Price Forecasts - Bộ Nội Vụ
Inotiv, Inc. Announces Strategic Collaboration with LifeNet Health to Enhance Drug Development with TruVivo® Technology - Quiver Quantitative
Inotiv Leverages LifeNet Health Proprietary Platform to Advance New Approach Methodologies in Translational Drug Discovery - Sahm
Inotiv Leverages LifeNet Health Proprietary Platform to - GlobeNewswire
Targets Report: Why Inotiv Inc stock is favored by pension funds2025 Volatility Report & AI Enhanced Trading Alerts - Bộ Nội Vụ
How Inotiv Inc. stock responds to policy changesMarket Sentiment Review & Weekly High Conviction Ideas - ulpravda.ru
Is Inotiv Inc. stock dividend yield sustainableInsider Selling & Smart Swing Trading Alerts - Улправда
Why Inotiv Inc. stock is rated strong buyMarket Performance Recap & Long-Term Safe Investment Plans - Улправда
Will Inotiv Inc. stock sustain high P E ratiosJuly 2025 Volume & Capital Protection Trade Alerts - Улправда
Inotiv in danger of delisting from Nasdaq - Inside INdiana Business
Will Inotiv Inc. (BS50) stock beat growth indexesForecast Cut & Detailed Earnings Play Strategies - Улправда
Block Trades: Is Inotiv Inc. stock dividend yield sustainable2025 Year in Review & High Accuracy Investment Signals - ulpravda.ru
Is Inotiv Inc. stock a safe investment in uncertain marketsBond Market & Stepwise Swing Trade Plans - Улправда
Is Inotiv Inc. stock affected by interest rate hikes2025 Bull vs Bear & Safe Entry Momentum Tips - Улправда
Can Inotiv Inc. stock attract ESG capital inflowsLayoff News & AI Enhanced Trading Signals - Улправда
Decliners Report: Can Inotiv Inc. stock attract ESG capital inflows2025 Price Action Summary & Consistent Profit Trading Strategies - Улправда
Is Inotiv Inc. stock oversold or undervaluedJuly 2025 Catalysts & Real-Time Volume Trigger Notifications - Улправда
Shorts Report: Will Inotiv Inc BS50 stock beat growth indexesShare Buyback & Smart Swing Trading Alerts - moha.gov.vn
Inotiv Receives Nasdaq Notice for Minimum Bid Noncompliance - TipRanks
Inotiv Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView — Track All Markets
Why Inotiv Inc. stock could rally in 20252026 world cup usa national team semifinals young talents high defensive line odds analysis tactical review - Улправда
Book value per share of Inotiv, Inc. – DUS:BS50 - TradingView — Track All Markets
Aug Weekly: nap sao 9029July 2025 Chart Watch & Fast Momentum Entry Tips - moha.gov.vn
Virginia dog rescue: 4,000 beagles in need of adoption after rescue from mistreatment at Envigo breeding facility - ABC30 Fresno
Inotiv, Inc. faces business risks amid FDA disruptions and government funding challenges - MSN
Revenue per share of Inotiv, Inc. – DUS:BS50 - TradingView — Track All Markets
Will Inotiv Inc. (BS50) stock extend growth storyJuly 2025 Rallies & Free Fast Entry Momentum Trade Alerts - Улправда
Can Inotiv Inc. (BS50) stock resist broad market declinesBreakout Watch & Verified Momentum Watchlists - Улправда
Will Inotiv Inc. stock rally after Fed decisionsMarket Volume Summary & Stock Timing and Entry Methods - Улправда
Is Inotiv Inc. stock near bottom after declineMarket Activity Recap & Precise Swing Trade Alerts - Улправда
Market Fear: Is Inotiv Inc stock dividend yield sustainable2025 Volume Leaders & Safe Capital Growth Tips - moha.gov.vn
New Highs: Will Alexander Baldwin Inc stock outperform foreign stocksWeekly Risk Report & Fast Gain Swing Alerts - moha.gov.vn
Inotiv partners with Vugene to advance AI-driven drug discovery - MSN
Inotiv, Inc. Partners with VUGENE to Advance AI-Driven Drug Discovery and Bioinformatics Capabilities - marketscreener.com
Inotiv partners with VUGENE to enhance AI-assisted drug discovery By Investing.com - Investing.com Canada
Inotiv partners with VUGENE to enhance AI-assisted drug discovery - Investing.com
Inotiv, Inc. and VUGENE Announce Strategic Collaboration to Enhance AI-Assisted Drug Discovery and Data Insights - Quiver Quantitative
Inotiv (NASDAQ: NOTV) and VUGENE align on AI drug discovery, bioinformatics push - Stock Titan
Inotiv Partners with VUGENE to Advance AI-Driven Drug Discovery and Bioinformatics Capabilities - Sahm
Inotiv : Investor Presentation December 2025 - marketscreener.com
Cyber CrimeInotiv Confirms Data Breach Exposing Sensitive Employee Information - teiss
NewsInotiv Confirms Data Breach Exposing Sensitive Employee Information - teiss
Drug R&D Firm Facing Costs, Lawsuits in Alleged Qilin Attack - Bank Info Security
Pharmaceutical Firm Inotiv Discloses Ransomware Attack and Data Breach - The HIPAA Journal
Major drug research company confirms cyberattack compromised employee and partner data - Cybersecurity Dive
Inotiv Inc Stock (NOTV) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.95%
1.36%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):